Ligase Market to be dominated by Rising Prevalence of Infectious, Genetic, and Chronic Diseases through 2027
Growing R&D activities
and growing need for disease treatment to drive the ligase market in the
forecast period, 2023-2027.
According to TechSci Research report, “Ligase
Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027”, the global ligase market is anticipated to grow at
a significant rate in the forecast period, 2023-2027. The rising incidence of infectious,
genetic, and chronic diseases, and extensive research and development are the
primary factors driving the demand for the global ligase market. Growing adoption
of advanced technology, expansion of diagnostics and pharmaceutical companies,
rise in world population, growing research & development, expansion of
biopharmaceutical industries and biopharma production, growing need of ligase
in disease treatment and heavy investments in healthcare sector are expected to
influence the market demand. Also, increasing strategic growth is also a key
factor for increasing the growth of the ligase market, globally.
However, the have minimal activity on short cohesive
and blunt substrates in end-joining reactions, and certain NAD-dependent
thermostable DNA ligase, which is used in vitro, can ligate only inadequate
number of nicks may hamper the growth of the global ligase market.
Browse over XX market
data Figures spread through 110 Pages and an in-depth TOC on "Ligase Market"
The global ligase market is
segmented into product, source, application, end user and company.
Based on product, the market
is segmented into quick ligase, T4 DNA ligase, E.Coli DNA ligase, T4 RNA
ligase, and others. The T4 DNA ligase segment is expected to hold the largest
market share. This is attributed to the most used ligase type among suppliers providing
kits and enzymes to their end users.
Based on source, the market
is segmented into archaebacterium, Escherichia coli, thermus thermophilus, and
others. The Escherichia coli segment is anticipated to grow during the
forecast period. This is attributed to widely used to unite the recombinant ends
of molecules prior to their launch into the cell.
Based on application, the
market is segmented into ligase chain reaction, ligase detection reaction, next
generation sequencing, molecular cloning, and
others. The molecular cloning segment is anticipated to grow during the
forecast period. This is attributed to wide applications, including the cloning
of stem cells, which aid in offering treatment for various diseases.
Based on end user, the market
is divided into biotechnology & pharmaceutical companies, academic &
research institutions, and others.
The academic & research institutions segment is
anticipated to grow during the forecast period. This is attributed to rising research
on the diagnostic application of ligase enzyme.
Major companies operating
in global ligase market are:
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Codexis, Inc.
- F. Hoffmann-La Roche AG
- Merck KGaA
- Promega Corporation
- QIAGEN N.V.
- ArcticZymes Technologies ASA
- Thermo Fisher Scientific, Inc.
- Takara Bio Inc.
Download Free Sample Report
Customers can also
request for 10% free customization on this report.
“North America region dominates the
market in 2021 and is expected to maintain its dominance in the coming years
due to the high occurrence of genetic defects and a rise in the number of
individuals needing long-term care in the region. Increase in investments for
R&D to promote the production of ligases as therapeutics for various,
presence of many leading players, the
well-established end-user industries, and extensive advancements in technology,
in the region is another key factor. Also,
the high number of firms with a strategic pipeline in the region are expected
to propel the global ligase market growth till 2027” said Mr. Karan Chechi,
Research Director with TechSci Research, a research based global management
consulting firm.
“Ligase Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented
By Product (Quick Ligase, T4 DNA Ligase,
E.Coli DNA Ligase, T4 RNA Ligase, Others), By Source (Archaebacterium,
Escherichia coli, Thermus thermophilus, Others), By Application (Ligase Chain
Reaction, Ligase Detection Reaction, Next Generation Sequencing, Molecular
Cloning, Others), By End User (Biotechnology & Pharmaceutical Companies,
Academic & Research Institutions, Others), By company and By Region”, has evaluated the future growth potential of global ligase
market and provides statistics & information on market size, structure, and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in global ligase market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com